Human mesenchymal stem cells and derived extracellular vesicles induce regulatory dendritic cells in type 1 diabetic patients

Diabetologia

Volumn 59, Issue 2, 2016, Pages 325-333

  Favaro, Enrica ^a   Carpanetto, Andrea ^a   Caorsi, Cristiana ^b   Giovarelli, Mirella ^b   Angelini, Costanza ^b   Cavallo Perin, Paolo ^a   Tetta, Ciro ^b,c   Camussi, Giovanni ^a   Zanone, Maria M ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c FRESENIUS MEDICAL CARE   (Germany)

Author keywords

Cytokines; Dendritic cells; Extracellular vesicles; GAD; Mesenchymal stem cells; Prostaglandin E2; T cells; Type 1 diabetes

Indexed keywords

CD14 ANTIGEN; GAMMA INTERFERON; GLUTAMATE DECARBOXYLASE 65; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 6;

ADULT; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL DIFFERENTIATION; CELL MATURATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DIABETIC PATIENT; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; EXOSOME; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; INTERNALIZATION; MALE; MIDDLE AGED; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH17 CELL; ULTRACENTRIFUGATION; YOUNG ADULT; CELL CULTURE; COCULTURE; CYTOLOGY; MESENCHYMAL STROMA CELL; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; ULTRASTRUCTURE;

ADULT; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; DENDRITIC CELLS; DIABETES MELLITUS, TYPE 1; EXTRACELLULAR VESICLES; FEMALE; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; YOUNG ADULT;

EID: 84953359550     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-015-3808-0     Document Type: Article

References (48)

1. Calderon B, Unanue ER (2012) Antigen presentation events in autoimmune diabetes. Curr Opin Immunol 24:119–128
2. Morel PA (2013) Dendritic cell subsets in type 1 diabetes: friend or foe? Front Immunol 4:1–11
3. Creusot RJ, Yaghoubi SS, Chang P et al (2009) Lymphoid-tissue-specific homing of bone-marrow-derived dendritic cells. Blood 113:6638–6647
4. Giannoukakis N, Phillips B, Finegold D, Harnaha J, Trucco M (2011) Phase I (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patients. Diabetes Care 34:2026–2032
5. Hilkens CM, Isaacs JD (2013) Tolerogenic dendritic cell therapy for rheumatoid arthritis: where are we now? Clin Exp Immunol 172:148–157
6. Creusot RJ, Giannoukakis N, Trucco M, Clare-Salzler MJ, Fathman CG (2014) It’s time to bring dendritic cell therapy to type 1 diabetes. Diabetes 63:20–30
7. Tai N, Yasuda H, Xiang Y et al (2011) IL-10-conditioned dendritic cells prevent autoimmune diabetes in NOD and humanized HLA-DQ8/RIP-B7.1 mice. Clin Immunol 139:336–349
8. Wang Y, Chen X, Cao W, Shi Y (2014) Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications. Nat Immunol 15:1009–1016
9. Djouad F, Charbonnier LM, Bouffi C et al (2007) Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism. Stem Cells 25:2025–2032
10. Li YP, Paczesny S, Lauret E et al (2008) Human mesenchymal stem cells license adult CD34+ hemopoietic progenitor cells to differentiate into regulatory dendritic cells through activation of the Notch pathway. J Immunol 1:1598–1608
11. Madec AM, Mallone R, Afonso G et al (2009) Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells. Diabetologia 52:1391–1399
12. Zanone MM, Favaro E, Miceli I et al (2010) Human mesenchymal stem cells modulate cellular immune response to islet antigen glutamic acid decarboxylase in type 1 diabetes. J Clin Endocrinol Metab 95:3788–3797
13. Carlsson PO, Schwarcz E, Korsgren O, Le Blanc K (2015) Preserved β-cell function in type 1 diabetes by mesenchymal stromal cells. Diabetes 64:587–592
14. Théry C, Ostrowski M, Segura E (2009) Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 9:581–593
15. Aggarwal S, Pittenger MF (2005) Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 15:1815–1822
16. Chiesa S, Morbelli S, Morando S et al (2011) Mesenchymal stem cells impair in vivo T cell priming by dendritic cells. Proc Natl Acad Sci U S A 18:17384–17389
17. Allen JS, Pang K, Skowera A et al (2009) Plasmacytoid dendritic cells are proportionally expanded at diagnosis of type 1 diabetes and enhance islet autoantigen presentation to T cells through immune complex capture. Diabetes 58:138–145
18. Guerder S, Joncker N, Mahiddine K, Serre L (2013) Dendritic cells in tolerance and autoimmune diabetes. Curr Opin Immunol 25:670–675
19. Jurewicz M, Yang S, Augello A et al (2010) Congenic mesenchymal stem cell therapy reverses hyperglycemia in experimental type 1 diabetes. Diabetes 59:3139–3147
20. Li FR, Wang XG, Deng CY, Qi H, Ren LL, Zhou HX (2010) Immune modulation of co-transplantation mesenchymal stem cells with islet on T and dendritic cells. Clin Exp Immunol 161:357–363
21. Favaro E, Carpanetto A, Lamorte S et al (2014) Human mesenchymal stem cell-derived microvesicles modulate T cell response to islet antigen glutamic acid decarboxylase in patients with type 1 diabetes. Diabetologia 57:1664–1673
22. Ganguly D, Haak S, Sisirak V, Reizis B (2013) The role of dendritic cells in autoimmunity. Nat Rev Immunol 13:566–577
23. Diana J, Simoni Y, Furio L et al (2013) Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes. Nat Med 19:65–73
24. Wakkach A, Fournier N, Brun V, Breittmayer JP, Cottrez F, Groux H (2003) Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 18:605–617
25. Melli K, Friedman RS, Martin AE et al (2009) Amplification of autoimmune response through induction of dendritic cell maturation in inflamed tissues. J Immunol 1:2590–2600
26. Perone MJ, Bertera S, Tawadrous ZS et al (2006) Dendritic cells expressing transgenic galectin-1 delay onset of autoimmune diabetes in mice. J Immunol 177:5278–5289
27. Bianco NR, Kim SH, Ruffner MA, Robbins PD (2009) Therapeutic effect of exosomes from indoleamine 2,3-dioxygenase-positive dendritic cells in collagen-induced arthritis and delayed-type hypersensitivity disease models. Arthritis Rheum 60:380–389
28. Kim SH, Lechman ER, Bianco N et al (2005) Exosomes derived from IL-10-treated dendritic cells can suppress inflammation and collagen-induced arthritis. J Immunol 174:6440–6448
29. Arif S, Moore F, Marks K et al (2011) Peripheral and islet interleukin-17 pathway activation characterizes human autoimmune diabetes and promotes cytokine-mediated β-cell death. Diabetes 60:2112–2119
30. Koch M, Lemke A, Lange C (2015) Extracellular vesicles from MSC modulate the immune response to renal allografts in a MHC disparate rat model. Stem Cells Int 486141:1–7
31. Krampera M, Glennie S, Dyson J et al (2003) Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 101:3722–3729
32. Quesenberry PJ, Aliotta J, Deregibus MC, Camussi G (2015) Role of extracellular RNA-carrying vesicles in cell differentiation and reprogramming. Stem Cell Res Ther 153:1–10
33. Cocucci E, Racchetti G, Meldolesi J (2009) Shedding microvesicles: artefacts no more. Trends Cell Biol 19:43–51
34. Akyurekli C, Le Y, Richardson RB, Fergusson D, Tay J, Allan DS (2015) A systematic review of preclinical studies on the therapeutic potential of mesenchymal stromal cell-derived microvesicles. Stem Cell Rev 11:150–160
35. Ratajczak MZ, Kucia M, Jadczyk T et al (2012) Pivotal role of paracrine effects in stem cell therapies in regenerative medicine: can we translate stem cell-secreted paracrine factors and microvesicles into better therapeutic strategies? Leukemia 26:1166–1173
36. Feili-Hariri M, Dong X, Alber SM, Watkins SC, Salter RD, Morel PAV (1999) Immunotherapy of NOD mice with bone marrow-derived dendritic cells. Diabetes 48:2300–2308
37. Zou T, Caton AJ, Koretzky GA, Kambayashi T (2010) Dendritic cells induce regulatory T cell proliferation through antigen-dependent and -independent interactions. J Immunol 1:2790–2799
38. Lo J, Peng RH, Barker T, Xia CQ, Clare-Salzler MJ (2006) Peptide-pulsed immature dendritic cells reduce response to beta cell target antigens and protect NOD recipients from type I diabetes. Ann N Y Acad Sci 1079:153–156
39. Creusot RJ, Yaghoubi SS, Kodama K (2008) Tissue-targeted therapy of autoimmune diabetes using dendritic cells transduced to express IL-4 in NOD mice. Clin Immunol 127:176–187
40. Fiorina P, Jurewicz M, Augello A et al (2009) Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes. J Immunol 183:993–1004
41. English K, Barry FP, Mahon BP (2008) Murine mesenchymal stem cells suppress dendritic cell migration, maturation and antigen presentation. Immunol Lett 15:50–58
42. Jonuleit H, Schmitt E, Schuler G, Knop J, Enk AH (2000) Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 6:1213–1222
43. Dhodapkar MV, Steinman RM, Krasovsky J, Munz C, Bhardwaj N (2001) Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med 15:233–238
44. Kordelas L, Rebmann V, Ludwig AK et al (2014) MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease. Leukemia 28:970–973
45. Kristiansen OP, Mandrup-Poulsen T (2005) Interleukin-6 and diabetes: the good, the bad, or the indifferent? Diabetes 54(Suppl 2):S114–S124
46. Boumaza I, Srinivasan S, Witt WT et al (2009) Autologous bone marrow-derived rat mesenchymal stem cells promote PDX-1 and insulin expression in the islets, alter T cell cytokine pattern and preserve regulatory T cells in the periphery and induce sustained normoglycemia. J Autoimmun 32:33–42
47. Di Caro V, Phillips B, Engman C, Harnaha J, Trucco M, Giannoukakis N (2013) Retinoic acid-producing, ex-vivo-generated human tolerogenic dendritic cells induce the proliferation of immunosuppressive B lymphocytes. Clin Exp Immunol 174:302–317
48. von Bahr L, Batsis I, Moll G et al (2012) Analysis of tissues following mesenchymal stromal cell therapy in humans indicates limited long-term engraftment and no ectopic tissue formation. Stem Cells 30:1575–1578